Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says
In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored
NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain
Sen. Pryor Attacks Drug Industry, NIH Technology Transfer
Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts
Trial Needed Of PSA To Determine Patients To Test, Chabner Says
DCT Advisors Okay PA In Imaging Patters Of Care RFA; Contracts
IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes
Trending Stories
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? - Cancer Research Institute announces 2025 recipients of cancer immunotherapy awards
- USPSTF doesn’t lean right or left—it’s about data, not politics
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts